Identification

Generic Name
Lumiflavin
DrugBank Accession Number
DB04726
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 256.26
Monoisotopic: 256.096025648
Chemical Formula
C13H12N4O2
Synonyms
  • 7,8,10-Trimethylbenzo(g)pteridine-2,4(3H,10H)-dione
  • 7,8,10-Trimethylisoalloxazine
  • Lumiflavin
  • Lumiflavine

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as flavins. These are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pteridines and derivatives
Sub Class
Alloxazines and isoalloxazines
Direct Parent
Flavins
Alternative Parents
Quinoxalines / Pyrimidones / Pyrazines / Benzenoids / Vinylogous amides / Heteroaromatic compounds / Lactams / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds
show 3 more
Substituents
Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Diazanaphthalene / Flavin / Heteroaromatic compound / Hydrocarbon derivative / Lactam / Organic nitrogen compound / Organic oxide
show 9 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
flavin (CHEBI:43661)
Affected organisms
Not Available

Chemical Identifiers

UNII
4M2669414M
CAS number
1088-56-8
InChI Key
KPDQZGKJTJRBGU-UHFFFAOYSA-N
InChI
InChI=1S/C13H12N4O2/c1-6-4-8-9(5-7(6)2)17(3)11-10(14-8)12(18)16-13(19)15-11/h4-5H,1-3H3,(H,16,18,19)
IUPAC Name
7,8,10-trimethyl-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione
SMILES
CN1C2=CC(C)=C(C)C=C2N=C2C(=O)NC(=O)N=C12

References

General References
Not Available
PubChem Compound
66184
PubChem Substance
46508913
ChemSpider
59571
BindingDB
50362897
ChEBI
43661
ChEMBL
CHEMBL1233985
ZINC
ZINC000000391159
PDBe Ligand
LFN
Wikipedia
Lumiflavin
PDB Entries
2ccc / 6asl

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.218 mg/mLALOGPS
logP0.52ALOGPS
logP1.66ChemAxon
logS-3.1ALOGPS
pKa (Strongest Acidic)5.97ChemAxon
pKa (Strongest Basic)-0.078ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area74.13 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity72.09 m3·mol-1ChemAxon
Polarizability26.32 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9964
Blood Brain Barrier+0.9856
Caco-2 permeable+0.6483
P-glycoprotein substrateNon-substrate0.6448
P-glycoprotein inhibitor INon-inhibitor0.6485
P-glycoprotein inhibitor IINon-inhibitor0.8776
Renal organic cation transporterNon-inhibitor0.8829
CYP450 2C9 substrateNon-substrate0.7296
CYP450 2D6 substrateNon-substrate0.7867
CYP450 3A4 substrateNon-substrate0.5155
CYP450 1A2 substrateInhibitor0.7028
CYP450 2C9 inhibitorNon-inhibitor0.9663
CYP450 2D6 inhibitorNon-inhibitor0.9885
CYP450 2C19 inhibitorNon-inhibitor0.9785
CYP450 3A4 inhibitorNon-inhibitor0.9574
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9816
Ames testAMES toxic0.6818
CarcinogenicityNon-carcinogens0.9231
BiodegradationNot ready biodegradable0.7891
Rat acute toxicity2.7796 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8988
hERG inhibition (predictor II)Non-inhibitor0.7221
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52